- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Sutent and Opdivo the Same Thing?
Sutent is used to treat gastrointestinal stromal tumor after disease progression on, or intolerance to imatinib mesylate, for advanced renal cell carcinoma, and for progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable, locally advanced or metastatic disease.
Opdivo is used to treat patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor; and to treat metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Side effects of Sutent and Opdivo that are similar include cough, nausea, vomiting, constipation, joint pain, fatigue, weakness, fever, diarrhea, abdominal pain, skin rash, loss of appetite, pain or swelling in the arms or legs, numbness or tingling, chest pain, and irregular heartbeat.
Side effects of Sutent that are different from Opdivo include unusual or unpleasant taste in the mouth, upset stomach, dry skin or cracked skin, changes in skin or hair color (yellow skin or lighter skin/hair), hair loss, back pain, tiredness, mouth pain/sores, blisters or rash on hands or feet, shortness of breath, bleeding, watery eyes, swelling around the eyes, and general ill feeling.
Side effects of Opdivo that are different from Sutent include itching, upper respiratory tract infection, muscle pain, swelling, weight loss, eye inflammation, infusion-related reactions, increased amylase, increased lipase, dizziness, skin peeling, skin redness, and psoriasis.
Sutent may interact with dexamethasone, imatinib, isoniazid, nefazodone, St. John's wort, antibiotics, antifungals, barbiturates, heart or blood pressure medications, HIV/AIDS medicines, medicines to treat narcolepsy, medications to treat osteoporosis or Paget's disease of bone, seizure medications, or grapefruit and grapefruit juice.
Opdivo may interact with other drugs.
What Are Possible Side Effects of Sutent?
Common side effects of Sutent include:
Side effects of Sutent include:
- unusual or unpleasant taste in the mouth
- upset stomach
- dry skin
- changes in skin or hair color (yellow skin or lighter skin/hair)
- hair loss
- joint pain
- back pain
- mouth pain/sores
- abdominal pain
- rash or other skin changes such as dry or cracked skin
- blisters or rash on hands or feet
- loss of appetite
- pain or swelling in the arms or legs
- numbness or tingling of the arms or legs
- shortness of breath
- watery eyes
- swelling around the eyes
- chest pain
- general ill feeling, or
- uneven heart rate.
Tell your doctor if you have serious side effects of Sutent including:
- easy bruising or bleeding,
- swelling ankles or feet,
- unusual weight changes,
- cold or heat intolerance,
- unusual tiredness,
- black or bloody stools,
- vomit that looks like coffee grounds,
- coughing up blood,
- slow wound healing,
- jaw pain,
- toe/joint/back pain,
- painful urination,
- cloudy/pink/bloody urine,
- changes in the amount of urine,
- muscle weakness/cramping/twitching,
- signs of low blood sugar (such as hunger, shakiness, fast heartbeat, sweating),
- mental/mood changes (such as decreased alertness, irritability, nervousness), or
- vision changes (such as decreased vision).
What Are Possible Side Effects of Opdivo?
Common side effects of Opdivo include:
- upper respiratory tract infection
- swelling of the extremities
- shortness of breath
- muscle pain
- decreased appetite
- abdominal pain
- chest pain
- joint pain
- weight loss
- irregular heartbeat
- eye inflammation
- infusion-related reactions
- increased amylase
- increased lipase
- numbness and tingling
- skin peeling
- skin redness and
What Is Sutent?
Sutent (sunitinib malate) is a multi-kinase inhibitor indicated for the treatment of gastrointestinal stromal tumor after disease progression on, or intolerance to imatinib mesylate, for advanced renal cell carcinoma, and for progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable, locally advanced or metastatic disease. Sutent is available in generic form.
What Is Opdivo?
Opdivo (nivolumab) is a human monoclonal antibody used to treat patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor; and to treat metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
What Drugs Interact With Sutent?
Sutent may interact with dexamethasone, imatinib, isoniazid, nefazodone, St. John's wort, antibiotics, antifungals, barbiturates, heart or blood pressure medications, HIV/AIDS medicines, medicines to treat narcolepsy, medications to treat osteoporosis or Paget's disease of bone, seizure medications, or grapefruit and grapefruit juice. Tell your doctor all medications and supplements you use.
What Drugs Interact With Opdivo?
Opdivo may interact with other drugs. Tell your doctor all medications and supplements you use.
How Should Sutent be Taken?
The recommended dose of Sutent (strengths available are 12.5, 25 and 50mg tablets). Sutent may be taken without food. Dose modification depends on the type of cancer treated and is determined by the treating doctor. Severe side effects include hepatotoxicity.
How Should Opdivo be Taken?
The recommended dose of Opdivo depends on the condition being treated and whether Opdivo is being administered as a single agent or in combination with another drug.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Bristol-Myers Squibb Company. Opdivo Product Information.